News FDA breached integrity over investigation of contaminated heparin BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c6529 (Published 16 November 2010) Cite this as: BMJ 2010;341:c6529 Article Related content Metrics Responses Peer review Related articles News Four deaths and 350 adverse events lead to US recall of heparin Published: 21 February 2008; BMJ 336 doi:10.1136/bmj.39496.419248.DB See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362